Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect GIPR GLP 1R dual agonist therapies for diabetes and weight losschemistry, physiology, and clinical applications ScienceDirect Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare Triple Agonism Based Therapies for Obesity Current Cardiovascular Risk Reports Springer Nature Link